RANO FALTAS: Open Payments
NPI 1992060891 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 28 payments from 9 companies in 2025. Trend: 2023 $1,483 · 2024 $2,244 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK NRO, Inc. | 10 | $276 |
| Abbott Laboratories | 9 | $173 |
| Boston Scientific Corporation | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Medtronic, Inc. | 1 | $26 |
| Saluda Medical Americas, Inc. | 1 | $23 |
| SPR Therapeutics, Inc | 2 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: Prospera, PROCLAIM, Intracept, Belbuca, INTELLIS ADAPTIVESTIM, Evoke, SPRINT PNS System, AUSTEDO XR.
Industry payments across MN — which companies pay providers there.
